Abstract
Melatonin is widely used for sleep disorders in patients with a range of developmental disorders and neurodisabilities, who also frequently have epilepsy. The aim of our review was to examine published data to assess the evidence for melatonin affecting seizure control. The literature search revealed 26 papers apparently reporting an association between melatonin and epilepsy or seizures but seven of these did not provide relevant information. Of the three double-blind, randomised, controlled trials, two showed no overall worsening or improvement in seizures, and one recent trial reported a statistically significant reduction in seizures. The open studies reported conflicting results. The few studies on the effect of seizures on melatonin levels have reported that baseline melatonin levels may be low in patients with uncontrolled epilepsy and that levels increase markedly following seizures. The striking finding of this review is the paucity of relevant data from the remarkably small number of studies. These results allow no firm conclusions to be drawn, although it would seem reasonable to observe that there was no marked overall effect on seizures, neither improvement nor worsening. There is a need for large, well designed, randomised, double-blind, placebo-controlled trials to establish the role of melatonin in either predisposing to or decreasing the likelihood of seizures.
References
Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet. 1998;351(9111):1254.
Sandyk R, Tsagas N, Anninos PA. Melatonin as a proconvulsive hormone in humans. Int J Neurosci. 1992;63(1–2):125–35.
Jan JE, Hamilton D, Seward N, et al. Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders. J Pineal Res. 2000;29(1):34–9.
Ross C, Davies P, Whitehouse W. Melatonin treatment for sleep disorders in children with neurodevelopmental disorders: an observational study. Dev Med Child Neurol. 2002;44(5):339–44.
Coppola G, Iervolino G, Mastrosimone M, et al. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial. Brain Dev. 2004;26(6):373–6.
Gupta M, Aneja S, Kohli K. Add-on melatonin improves sleep behavior in children with epilepsy: randomized, double-blind, placebo-controlled trial. J Child Neurol. 2005;20(2):112–5.
Elkhayat HA, Hassanein SM, Tomoum HY, et al. Melatonin and sleep-related problems in children with intractable epilepsy. Pediatr Neurol. 2010;42(4):249–54.
Duncan JS, Sander JW. The Chalfont Seizure Severity Scale. J Neurol Neurosurg Psychiatry. 1991;54(10):873–6.
Stern JM, Engel J Jr. Atlas of EEG patterns. Philadelphia: Lippincott Williams & Wilkins; 2005.
Andersen IM, Kaczmarska J, McGrew SG, et al. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. 2008;23(5):482–5.
Jones C, Huyton M, Hindley D. Melatonin and epilepsy. Arch Dis Child. 2005;90(11):1203.
Fauteck J, Schmidt H, Lerchl A, et al. Melatonin in epilepsy: first results of replacement therapy and first clinical results. Biol Signals Recept. 1999;8(1–2):105–10.
Saracz J, Rosdy B. Effect of melatonin on intractable epilepsies [in Hungarian]. Orv Hetil. 2004;145(51):2583–7.
Peled N, Shorer Z, Peled E, et al. Melatonin effect on seizures in children with severe neurologic deficit disorders. Epilepsia. 2001;42(9):1208–10.
Molina-Carballo A, Muñoz-Hoyos A, Reiter RJ, et al. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years’ experience. J Pineal Res. 1997;23(2):97–105.
Uberos J, Augustin-Morales MC, Molina CA, et al. Normalization of the sleep-wake pattern and melatonin and 6-sulphatoxy-melatonin levels after a therapeutic trial with melatonin in children with severe epilepsy. J Pineal Res. 2011;50(2):192–6.
Goldberg-Stern H, Oren H, Peled N, et al. Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study. J Child Neurol. 2012;27(12):1524–8.
Yalyn O, Arman F, Erdogan F, et al. A comparison of the circadian rhythms and the levels of melatonin in patients with diurnal and nocturnal complex partial seizures. Epilepsy Behav. 2006;8(3):542–6.
Molina-Carballo A, Muñoz-Hoyos A, Sanchez-Forte M, et al. Melatonin increases following convulsive seizures may be related to its anticonvulsant properties at physiological concentrations. Neuropediatrics. 2007;38(3):122–5.
Bazil CW, Short D, Crispin D, et al. Patients with intractable epilepsy have low melatonin, which increases following seizures. Neurology. 2000;55(11):1746–8.
Schapel GJ, Beran RG, Kennaway DL, et al. Melatonin response in active epilepsy. Epilepsia. 1995;36(1):75–8.
Gordon N. The therapeutics of melatonin: a paediatric perspective. Brain Dev. 2000;22(4):213–7.
Acuna CD, Rosenstein RE, Romeo HE, et al. Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administration to rats. Neuroendocrinology. 1986;43(1):24–31.
Gupta M, Gupta YK, Agarwal S, et al. A randomized, double-blind, placebo controlled trial of melatonin add-on therapy in epileptic children on valproate monotherapy: effect on glutathione peroxidase and glutathione reductase enzymes. Br J Clin Pharmacol. 2004;58(5):542–7.
Muñoz-Hoyos A, Sánchez-Forte M, Molina-Carballo A, et al. Melatonin’s role as an anticonvulsant and neuronal protector: experimental and clinical evidence. J Child Neurol. 1998;13(10):501–9.
Lima E, Cabral FR, Cavalheiro EA, et al. Melatonin administration after pilocarpine-induced status epilepticus: a new way to prevent or attenuate postlesion epilepsy? Epilepsy Behav. 2011;20(4):607–12.
Solmaz I, Gurkanlar D, Gokcil Z, et al. Antiepileptic activity of melatonin in guinea pigs with pentylenetetrazol-induced seizures. Neurol Res. 2009;31(9):989–95.
Stewart LS. Endogenous melatonin and epileptogenesis: facts and hypothesis. Int J Neurosci. 2001;107(1–2):77–85.
Fauteck JD, Bockmann J, Bockers TM, et al. Melatonin reduces low-Mg2+ epileptiform activity in human temporal slices. Exp Brain Res. 1995;107(2):321–5.
Rufo-Campos M. Melatonin and epilepsy [in Spanish]. Rev Neurol 2002;35Suppl.1:S51-8.
Sanchez-Forte M, Moreno-Madrid F, Munoz-Hoyos A, et al. The effect of melatonin as anti-convulsant and neuron protector (in Spanish). Rev Neurol. 1997;25(144):1229–34.
Conflict of interest
Neither author has any conflict of interests relating to the subject matter of this paper.
Sources of funding
No funding was received for the preparation or writing of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jain, S., Besag, F.M.C. Does Melatonin Affect Epileptic Seizures?. Drug Saf 36, 207–215 (2013). https://doi.org/10.1007/s40264-013-0033-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40264-013-0033-y